Coronavirus Update: NJ Company Celularity Seeks FDA Approval For Cell Therapy To Fight COVID-19

Name: Coronavirus Update: NJ Company Celularity Seeks FDA Approval For Cell Therapy To Fight COVID-19
Uploaded: 2020-04-01T01:16:14+00:00
Duration: P126S
Description: A New Jersey company that uses cell therapy for cancer patients is still awaiting FDA approval to try its coronavirus treatment; CBS2's Nick Caloway reports.

Credit: CBS 2 New York

Duration: 02:06s 01 Apr 2020 0 shares 1 views

Coronavirus Update: NJ Company Celularity Seeks FDA Approval For Cell Therapy To Fight COVID-19

A New Jersey company that uses cell therapy for cancer patients is still awaiting FDA approval to try its coronavirus treatment; CBS2's Nick Caloway reports.

Coronavirus Update: NJ Company Celularity Seeks FDA Approval For Cell Therapy To Fight COVID-19

You might like